Symbol="BTAI"
AssetType="Common Stock"
Name="BioXcel Therapeutics Inc"
Description="BioXcel Therapeutics, Inc., a clinical-phase biopharmaceutical company, focuses on the development of artificial intelligence-based drugs in the fields of neuroscience and immuno-oncology in the United States. The company is headquartered in New Haven, Connecticut."
CIK="1720893"
Exchange="NASDAQ"
Currency="USD"
Country="USA"
Sector="LIFE SCIENCES"
Industry="PHARMACEUTICAL PREPARATIONS"
Address="555 LONG WHARF DRIVE, NEW HAVEN, CT, US"
FiscalYearEnd="December"
LatestQuarter="2023-03-31"
MarketCapitalization="295678000"
EBITDA="-179032992"
PERatio="None"
PEGRatio="None"
BookValue="1.821"
DividendPerShare="0"
DividendYield="0"
EPS="-3.82"
RevenuePerShareTTM="0.021"
ProfitMargin="0"
OperatingMarginTTM="-308.71"
ReturnOnAssetsTTM="-0.573"
ReturnOnEquityTTM="-1.515"
RevenueTTM="581000"
GrossProfitTTM="355000"
DilutedEPSTTM="-3.82"
QuarterlyEarningsGrowthYOY="0"
QuarterlyRevenueGrowthYOY="0"
AnalystTargetPrice="42.7"
TrailingPE="-"
ForwardPE="-"
PriceToSalesRatioTTM="4131.89"
PriceToBookRatio="3.966"
EVToRevenue="2657.94"
EVToEBITDA="-2.748"
Beta="0.84"
num_52WeekHigh="34.12"
num_52WeekLow="5.88"
num_50DayMovingAverage="20.15"
num_200DayMovingAverage="20.2"
SharesOutstanding="29159600"
DividendDate="None"
ExDividendDate="None"
symbol="BTAI"
open="10.03"
high="10.15"
low="9.26"
price="10.14"
volume="3923138.00"
latest_trading_day="2023-07-10"
previous_close="10.17"
change="-0.03"
change_percent="-0.2950%"
aroon_positive_momentum_days="0"
aroon_negative_momentum_days="60"
trend_strength="Absent or Weak Trend"
buying_signal="Weak Sell Signal"
volume_analysis="Target Volume"
value_analysis="Expected Range"
Aroon_change="FALSE"
Aroon_momentum="40"
Volume_recent_avg="1679033"
Change_recent_avg="-0.11"
Delta_recent_avg="1.64"
Variance_recent_avg="0.82"
Change_ratio_recent_avg="-0.67"
RSI_change="FALSE"
ADX_change="FALSE"

event="FALSE"
Aroon_signal="negative"
Aroon_change="FALSE"
Aroon_momentum_positive="40"
Aroon_momentum_negative="60"
image_negative_thumbnail_id_1="1113"
image_negative_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Negative_Landscape_0146.jpeg"
image_negative_thumbnail_id_2="1165"
image_negative_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Negative_Landscape_0199.jpeg"
image_neutral_thumbnail_id_1="562"
image_neutral_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0037.jpeg"
image_neutral_thumbnail_id_2="547"
image_neutral_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0052.jpeg"
image_positive_thumbnail_id_1="957"
image_positive_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0119.jpeg"
image_positive_thumbnail_id_2="622"
image_positive_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0086.jpeg"
image_professor_thumbnail_id_1="1204"
image_professor_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0038.jpeg"
image_professor_thumbnail_id_2="1202"
image_professor_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0036.jpeg"
